Possible Genetic Links Between Hidradenitis Suppurativa and CAD, Diabetes Risks
November 11th 2024In this study, investigators were seeking to uncover potential genetic correlations between hidradenitis suppurativa and downstream risk of cardiometabolic disease, such as coronary artery disease (CAD) and diabetes, in older adults.
Read More
Fixed-Duration 1L CLL Treatment Reduces Long-Term Costs in the Real World
November 9th 2024The venetoclax-based regimen was associated with an approximate $8000 decrease in costs compared with the continuous Bruton tyrosine kinase inhibitor treatment 6 months after the fixed-duration period.
Read More
Health Equity & Access Weekly Roundup: November 9, 2024
November 9th 2024The health policy implications and ballot measures in the wake of the presidential election, new trends in physician compensation, lessons from the Medicaid unwinding, disparities in cancer mortality, and privately negotiated hospital fees.
Read More
Study Explores Radiation-Free Transplant Approach for Patients With Dyskeratosis Congenita
November 8th 2024A new study finds that eliminating radiation from conditioning regimens in patients with dyskeratosis congenita undergoing allogeneic hematopoietic cell transplantation did not negatively affect survival or increase complications.
Read More
Exploring Metabolic Links to Cognitive Impairment in MS
November 8th 2024The complex relationship between possibly impaired cognitive function in patients with multiple sclerosis (MS) and fasting blood sugar, fasting insulin, and insulin sensitivity levels is the focus of new work that advances understanding of intricate biological connections.
Read More
Enhancing Myasthenia Gravis Care With AI-Powered Telemedicine
November 8th 2024Researchers introduce a telemedicine system powered by artificial intelligence (AI) that automatically scores neuromuscular examinations, offering the potential to enhance patient monitoring, reduce variability in clinical trials, and improve access to care for neuromuscular disorders like myasthenia gravis.
Read More
Understanding Cognitive Aging: Insights From 25-Year Study
November 7th 2024A 25-year study of the Lothian Birth Cohorts found that childhood intelligence, lifestyle factors, and brain white matter health significantly impact cognitive aging and longevity, highlighting the importance of consent, ethics, and biological sample collection in ongoing research.
Read More
Lessons Learned From Medicaid Unwinding as States Tackle Eligibility Checks
November 7th 2024Medicaid and CHIP enrollment surged from 71 million in February 2020 to 94 million by April 2023. However, with the pandemic emergency ending in May 2023, states resumed eligibility reviews, initiating a process termed “unwinding.”
Read More
Eque-Cel CAR T Shows Strong Results for Multiple Myeloma
November 7th 2024Multiple myeloma is the second most common hematologic malignancy, but there is a treatment gap for patients with disease progression following standard-of-care therapies that include immunomodulatory agents, proteasome inhibitors, and anti-CD38 antibodies.
Read More
Next-Gen Hemophilia Treatments Offer Hope for Joint Health, but Accessibility Challenges Remain
November 7th 2024The future of hemophilia care lies not only in technological advancements but also in the pursuit of health equity, ensuring that all patients have access to effective, affordable treatments.
Read More
KIR2DS2+ NK Cells Show Potential in HCC and Leukemia Treatment
November 6th 2024These findings suggest that KIR2DS2-positive (KIR2DS2+) natural killer (NK) cells could be an attractive therapeutic target for in vivo strategies, although enhanced effector function is lost during ex vivo expansion needed for NK cell–based therapies, such as chimeric antigen receptor–NK cell treatment.
Read More
FDA Q&A: Addressing Biosimilar Safety, AI in Drug Development, and Supply Chain Challenges
November 6th 2024In a Q&A, an FDA spokesperson discusses efforts to reduce misinformation about biosimilars through education, the agency’s collaboration with global regulators to streamline development, and its work to address drug shortages while emphasizing safety, efficacy, and public trust.
Read More